Cash & equivalents increased 83.3%
Cash & equivalents changed +83.3% from the comparable as-filed period.
$3.3M→$6.0M2 prior comparisons
GROSSPATTERN / DETERMINISTIC EVIDENCE / V3
Search securities →TKNO financial changes
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Gross profit increased 22.6%
Gross profit changed +22.6% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
$4.0M→$4.9M4 prior comparisons
Operating margin moved 920 bp higher
Operating margin changed +920 basis points from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
-32.92%→-23.72%4 prior comparisons
Revenue increased 18.5%
Revenue changed +18.5% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
$10.3M→$12.2M4 prior comparisons
Stock-based compensation decreased 34.5%
Stock-based compensation changed -34.5% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
$950,000→$622,0004 prior comparisons
Operating income increased 14.6%
Operating income changed +14.6% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
-$3.4M→-$2.9M4 prior comparisons
Gross margin moved 136 bp higher
Gross margin changed +136 basis points from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
38.73%→40.09%4 prior comparisons
Inventory decreased 9.2%
Inventory changed -9.2% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
$7.6M→$6.9M4 prior comparisons
Net income increased 11.2%
Net income changed +11.2% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
-$3.6M→-$3.2M4 prior comparisons
Debt increased 1.4%
Debt changed +1.4% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
$13.0M→$13.2M4 prior comparisons
Research & development decreased 4.6%
Research & development changed -4.6% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
$581,000→$554,0004 prior comparisons
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.